Cargando…

Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

Carcinoid heart disease (CHD) occurs in 20–70% of the patients with metastatic well-differentiated neuroendocrine tumours (NET). We evaluated whether natriuretic peptides (ANP or NT-proBNP) are useful in early detection of CHD. Blood samples from 32 patients with NET were compared with cardiac ultra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuetenhorst, J M, Korse, C M, Bonfrer, J M G, Bakker, R H, Taal, B G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409483/ https://www.ncbi.nlm.nih.gov/pubmed/15150565 http://dx.doi.org/10.1038/sj.bjc.6601816

Ejemplares similares

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation
por: Meij, Vincent, et al.
Publicado: (2005)

Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites
por: Van Doornum, G J J, et al.
Publicado: (2003)

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality
por: Dobson, R, et al.
Publicado: (2014)

Carcinoid Heart Disease on Computed Tomography
por: Hardy, Jean-Philippe, et al.
Publicado: (2020)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
por: Kadri, Amer N., et al.
Publicado: (2018)

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?
por: Martín, Ernesto, et al.
Publicado: (2022)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease
por: Alves, Carolina, et al.
Publicado: (2018)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
por: Levy, Sonja, et al.
Publicado: (2022)

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
por: Palazzuoli, Alberto, et al.
Publicado: (2013)

Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease
por: Andrushchuk, Uladzimir, et al.
Publicado: (2022)

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
por: Bonfrer, J. M., et al.
Publicado: (1998)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
por: Troughton, Richard W., et al.
Publicado: (2014)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
por: Taylor, Clare J, et al.
Publicado: (2022)

Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure
por: Breidthardt, Tobias, et al.
Publicado: (2022)

Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study
por: Roalfe, Andrea K, et al.
Publicado: (2021)

Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke
por: Sayan, Saadet, et al.
Publicado: (2016)

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours
por: Korse, C M, et al.
Publicado: (2011)

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017)

Carcinoid heart disease
por: Geller, Stephen A., et al.
Publicado: (2013)

Importance of Basal Metabolic Index in the Diagnosis of Heart Failure With B-Type Natriuretic Peptide
por: Ullah, Waqas, et al.
Publicado: (2019)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018
por: Taylor, Clare J, et al.
Publicado: (2022)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Primary Testicular Carcinoid Tumor presenting as Carcinoid Heart Disease
por: Chikkaraddi, Manjunath L., et al.
Publicado: (2015)

Cases in a series of carcinoid syndrome and carcinoid heart disease
por: Mamotabo, R Matshela
Publicado: (2018)

Modified natriuretic peptides and their potential roles in cancer treatment
por: Xu, Mengjiao, et al.
Publicado: (2022)

Carcinoid Right Heart Disease
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2020)

Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
por: Hofland, Johannes, et al.
Publicado: (2021)

Carcinoid Heart Disease From a Primary Liver Carcinoid Tumor
por: Gudiño-González, Juan Carlos, et al.
Publicado: (2022)

Multimodality imaging in carcinoid heart disease
por: Agha, Ali M, et al.
Publicado: (2019)

A Case of Carcinoid Syndrome Due to Malignant Metastatic Carcinoid Tumor with Carcinoid Heart Disease Involving Four Cardiac Valves
por: Shinn, Brianna J., et al.
Publicado: (2018)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease
por: Sharma, Abhishek, et al.
Publicado: (2015)

The Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac Diseases
por: Arjamaa, Olli
Publicado: (2021)

The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1qemlqv07f8322g9u6qonu0o8n